(Reuters Health) – Cancer death rates in the United States fell 2.2% from 2016 to 2017 – the largest single-year drop ever recorded – fueled in large part by progress against lung cancer, the leading cause of cancer death, the American Cancer Society (ACS) rep... More »
JERUSALEM (Reuters) – Israel’s IceCure Medical said on Sunday it received U.S. regulatory approval to expand the use of its cryoablation technology to treat benign and cancerous tumors in livers and kidneys, sending its share price up 30%. IceCure’s treatment ... More »
(Reuters Health) – Cancer specialists only rarely advise patients on lifestyle changes that could improve overall health and possibly also reduce the risk of recurrence, a new survey suggests. The survey of doctors from a Midwestern health system found that on... More »
(Reuters Health) – Patients who see their doctors in the morning are a lot more likely to be referred for screenings for breast and colon cancer than patients with end-of-the-day appointments, a new study suggests. Researchers poring over records of more than ... More »
BUENOS AIRES (Reuters) – Amid a swirling economic crisis and protests over budget cuts for research in Argentina, one scientist has found a novel way to fundraise: winning money on a television game show. Marina Simian, a biologist for Argentina’s National Sci... More »
(Reuters Health) – Patients may have less access to palliative care at U.S. hospitals that primarily serve minorities, a study suggests. Minorities in the U.S. often receive worse healthcare and have worse outcomes, researchers note in JAMA Network Open. Non-w... More »
(Reuters Health) – – Breast cancer survivors may be more likely to experience anxiety, depression, sleep troubles and other mental health issues than women who have not been diagnosed with the disease, a research review suggests. The study team examined data f... More »
(Reuters Health) – U.S. flight attendants may be more likely than other Americans to develop several types of cancer including tumors of the breast, uterus, cervix, thyroid and skin, new research suggests. “This study is the first to show higher prevalences of... More »
CHICAGO (Reuters) – Some 70 percent of women with early-stage breast cancer and an intermediate risk of cancer recurrence can safely skip chemotherapy after their tumors have been removed, U.S. researchers said on Sunday. “This is a major finding,” said Dr. La... More »
(Reuters Health) – The cost of new anti-cancer drugs increased more than five-fold from 2006 to 2015, but a new analysis suggests that cancer patients and insurers may be getting less for their money. Anticancer medications account for the lion’s share of glob... More »
(Reuters Health) – Most Americans aren’t aware of cancer drug shortages that might lead some patients to receive less effective or more toxic treatments, a U.S. study suggests. In a nationally representative survey of 420 adults, just 16 percent said they knew... More »
(Reuters) – A European Medicines Agency (EMA) panel on Friday recommended against approving Puma Biotechnology’s lead breast cancer drug, an outcome the U.S drugmaker had signaled last month. The EMA said the Committee for Medicinal Products for Human Use (CHM... More »
Professor Ketan Patel works in the lab at MRC Laboratory of Molecular Biology in Cambridge, Britain January 2, 2018. Picture taken January 2, 2018. REUTERS/Chris Radburn LONDON (Reuters) – Drinking alcohol produces a harmful chemical in the body which can lead... More »
Emmy-winning comedic actress Julia Louis-Dreyfus said on Thursday that she was battling breast cancer and highlighted the case for universal healthcare. More »
The U.S. Food and Drug Administration said on Thursday it approved an Eli Lilly and Co drug to treat advanced breast cancer that has progressed following prior treatment. More »
Eli Lilly staked its claim for a slice of sales in a new class of breast cancer drugs on Sunday as clinical data showed adding its medicine abemaciclib to standard therapy reduced the risk of disease progression by 46 percent. More »
The alcohol industry uses denial, distortion and distraction to mislead people about the risks of developing cancer from drinking, often employing similar tactics to those of the tobacco industry, a study said on Thursday. More »
By Andrew M. Seaman(Reuters Health) – People who want access to the best cancer treatment centers in the U.S. may want to avoid health insurance pla More »
By Carolyn Crist(Reuters Health) – Cancer patients receiving chemotherapy should have all their medications and herbal supplements reviewed by a phar More »
By Lisa Rapaport(Reuters Health) – After an abnormal mammogram, Asian women in the U.S. are less likely than white women to get follow-up tests to de More »
Puma Biotechnology Inc’s experimental breast cancer drug reduces the risk of disease recurrence and should be approved, an advisory committee to the U.S. Food and Drug Administration concluded on Wednesday. More »
A screen displays the share price for pharmaceutical maker AbbVie on the floor of the New York Stock Exchange July 18, 2014. Shire said on July 18 that it had accepted an offer of 32 billion pounds ($54.7 billion) from AbbVie. REUTERS/Brendan McDermid AbbVie I... More »
By Will Boggs MD(Reuters Health) – If you have early-stage breast cancer and have undergone genetic testing, the odds are high that the results were More »
By Lisa Rapaport(Reuters Health) – Comfort care for advanced cancer patients is associated with fewer repeat hospitalizations and more hospice referr More »
By Lisa Rapaport(Reuters Health) – – Internet-based psychotherapy focused on changing behavior may be tied to improved body image and sexual function More »
By Ronnie Cohen(Reuters Health) – Poor women undergoing breast cancer treatment are four times more likely to lose their jobs than their high-income More »
By Madeline Kennedy(Reuters Health) – As cancer drug costs rise, U.S. cancer patients are more likely than other medical patients to struggle with pa More »
FILE PHOTO: Packets of Herceptin sit on a pharmacy shelf in London, Britiain, June 9, 2006. REUTERS/Luke MacGregor/File Photo Treatment with two important cancer drugs is about to get much cheaper in Europe with a cut-price copy of Roche’s blood cancer drug Ri... More »
By Lisa Rapaport(Reuters Health) – Doctors may diagnose breast cancer later and be less likely to offer needed radiation for Hispanic immigrants than More »
By Lisa Rapaport(Reuters Health) – Women whose breasts are composed mainly of dense glandular tissue rather than fat may have higher odds of developi More »
By Andrew M. Seaman(Reuters Health) – In general, childhood cancer survivors are just as satisfied with their sex lives as people who didn’t have ca More »
By Andrew M. Seaman(Reuters Health) – The number of older women in the U.S. being screened for breast cancer increased after the Affordable Care Act More »
By Lisa Rapaport(Reuters Health) – Widespread breast cancer screening may catch more small, slow-growing tumors that are unlikely to be fatal without More »
By Andrew M. Seaman(Reuters Health) – Drugs recently approved around the world to fight cancer increased patients’ overall survival, but benefits va More »
By Lisa Rapaport(Reuters Health) – Women with cancer in one breast may opt to have both breasts removed even though a double mastectomy isn’t always More »
By Kathryn Doyle(Reuters Health) – For patients with advanced cancer, palliative care should start early and be an integral part of treatment, not ju More »
By Lisa Rapaport(Reuters Health) – Chemotherapy regimens for breast cancer can vary wildly in price even when they are comparable in their ability to More »
By Lisa Rapaport(Reuters Health) – Women with early-stage breast cancer may have fewer treatment complications and lower costs when they don’t get a More »
(Reuters Health) – U.S. doctors and hospitals throw out almost $3 billion (roughly 2.7 billion euros) in unused cancer drugs each year because the medicines come in supersized single-use packages and excess medicine must be discarded for safety reasons, a rece... More »
